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Background: There has been extensive research in the study of the dog genome and comparative 
genomics to human diseases. Dogs were proposed as a candidate primarily because of the 
relatively low variation within breeds but high variation between breeds. In this study, we used a 
conserved gene among dogs, SMN, to understand the genetic variability across dog breeds and to 
compare with human SMN1.  
Methods: Using a sequential method design, new dog samples are added into the database as 
they become available. This paper is an application of the newly developed algorithms in 
studying the similarities and differences in genes between dogs and humans. 
Results: In our analysis, we isolated the sequence for SMN across three dogs (two English 
Bulldogs and one French Mastiff) and compared the sequence to the reference dog SMN 
sequence. We identified a number of SNPs but the differences were located in the intron region 
suggesting that potential difference in the exon regions may exhibit deleterious effects in the 
animal. The total genetic variation we observed in our three dog samples is less than 1%. When 
comparing the reference dog SMN to human SMN1, we observed conserved sequences 
predominantly within the exon region of SMN1. The conserved sequences located in the intron 
region between SMN1 and dog SMN may suggest that those regions may serve a regulatory 
function in gene expression.   
Conclusion: There were no meaningful genetic variation within the exon region among our dog 
samples for SMN. As additional dog sequences from different breeds are acquired, the 
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In leveraging the application of NGS technology, the genome of Canis lupus familiaris or 
dogs was selected as a model for studying human conditions. Dogs have been proposed as a 
potential candidate for comparative gene mapping and disease identification among humans 
(Deschenes et al. 1994; Parker et al. 2010). There has been extensive research in the study of the 
dog genome and comparative genomics to human diseases by Elaine Ostrander and her team in 
the past two decades. Ostrander proposes that dogs serve as an excellent model for investigating 
complex human diseases. Firstly, dogs and humans share similar health diseases that may be 
caused by similar genes between the two species such as cancer and autoimmune diseases (Sutter 
and Ostrander et al. 2004; Parker et al. 2010). Secondly, the unique breeding patterns for dogs 
have led to a relatively phenotypic homogeneous population thereby reducing genetic diversity 
within breeds (Ostrander et al. 2010). Lastly, dogs and humans share similar environmental 
exposures and so the history of disease onset and progression may be similar between these two 
species (Shearin et al. 2010).   
The dog genome contains approximately 3 billion base pairs and 39 pairs of 
chromosomes (NHGRI 2018). It is estimated that about 25% of the dog sequence aligns to the 
human genome (Kirkness et al. 2003) making the dog an attractive model for comparative 
analysis in understanding the genetic basis of diseases between dogs and humans. In this project, 
the Illumina NGS technology will be used to sequence the genome of the English Bulldog and 
French Mastiff with 30-times read coverage. Not only has this technique never been applied in 
this form of research and it will expand upon existing knowledge about the dog genome, and will 
be used as a comparison to the existing reference genome. Compared to other NGS technologies 
(SOLiD system, Roche 454 system, and Illumina HiSeq system), Illumina’s HiSeq system 
generates the greatest sequencing output at the lowest operating cost (Liu et al. 2012).  
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Through employing the Illumina sequencing system to generate reads for the dog 
genome, we will investigate a highly conserved gene across dog breeds, comparing it with the 
human gene equivalent. The study of comparative genomics is a growing field and with 
advancing technology, there is a need for new algorithms to handle large datasets. Comparing the 
conserved genes across species to identify regions of similarity and difference may allow 
researchers to better understand the structure and function of human genes, health conditions, 
and ultimately improve treatment options. Identifying DNA sequences that have been preserved 
in different dog breeds and in humans may contribute to the development of innovative 
treatments for complex human diseases that would enhance health.  
The conserved gene of interest within the dog genome in this study is SMN. SMN or 
survival motor neuron is a gene associated with the human condition, spinal muscular atrophy or 
SMA (Nizzardo et al. 2015). Humans have two copies of the gene, SMN1 and SMN2, both of 
which express the survival motor neuron (SMN) protein. This protein is highly expressed in the 
spinal cord and is critical for the function of motor neurons. By studying the gene in another 
species, we may decode the mystery and understand the structure and function of the conserved 
gene. This knowledge may be valuable in developing newer therapies in addressing the medical 
needs for patients with SMA.   
Methods 
Using a sequential method design, new samples are added into the database as they become 
available. This paper is an application of the newly developed algorithms in studying the 
similarities and differences in genes between dogs and humans. The overall aim of the project is 
to study the genetic variation among conserved genes in dogs and to understand the function it 
may serve in order to investigate human diseases. In this study, we will be studying a highly 
conserved gene, SMN, to study the genetic variability across dog breeds and to compare the gene 
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with the human equivalent. Refer to Table 1 for characteristics of the dogs. There are three sub-
aims 
1. In a sequential manner, collect and prepare blood sample from dogs for Next Generation 
Whole Genome Sequencing. 
2. Utilize Illumina platform to perform WGS technology to sequence the samples. 
3. Apply the analysis of SMN and identify conserved regions, biological relevant SNPs and 
indels within promoter and/or exon regions if applicable.  
The analysis is conducted on the initial three dog samples acquired.  
DNA Extraction 
Blood samples were purified and extracted using the QIAamp Blood Midi Kit (Spin Protocol). 
Two milliliters of whole blood were collected per tube and 1x PBS was used to bring the volume 
of the sample up to 2 ml if necessary before proceeding to purify and extract genomic DNA. 
Purified and extracted DNA samples were stored at -20°C. The concentration of the purified 
DNA was determined via the Nanodrop spectrophotometer and by PicoGreen Assay before 
library preparation. These samples were then sent to Yale Center for Genome Analysis (YCGA) 
for Next Generation DNA sequencing. 
NanoDrop DNA Quantification 
Table 3 provides the recorded concentration for five representative dog samples via the 
NanoDrop. The three dog samples (1Y, 2O, and MW) used for analysis was not incorporated in 
the table. 
The Nanodrop spectrophotometer is a common lab instrument used to measure the concentration 
of DNA and the A260/280 ratio indicates potential sources of contamination among the samples. 
Blood samples from five dogs were extracted and purified. Depending on the amount of blood 
available for extraction, some samples were divided into two or four vials. As we do not have 
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control over the amount of leftover blood for collection, we maximized the amount of genomic 
DNA extracted when possible. Samples 1 and 2 were divided into four vials for DNA extraction 
and purification. Sample 3,4 and 5 were divided into two vials for DNA extraction and 
purification. 
PicoGreen Assay 
Table 4 provides the recorded concentration for five representative dog samples via the 
PicoGreen Assay. The three dog samples (1Y, 2O, and MW) used for analysis was not 
incorporated in the table.  
The Pico Green DNA quantification assay is a sensitive method to detect small amounts of 
double stranded DNA in samples through a DNA binding fluorescent dye. The assay reports an 
exact concentration of the purified genomic DNA samples.  
Whole Genome Sequencing by NGS technology 
2ug of genomic DNA as measured by the PicoGreen assay was required for the PCR-FREE 
library prep approach.  Sequencing was run on the Illumina NovaSeq 6000 and 30X depth. The 
Illumina platform used bridge amplification for sequencing by synthesis. Paired end reads were 
generated to maximize coverage and confidence in determining sequence. 
Alignment and Extraction of aligned reads 
The Burrow-Wheeler Aligner (BWA) software package was used for mapping sequences to a 
reference genome (CANFAM3.1) (Heng et al. 2009). The BWA-MEM algorithm was used and 
alignments were outputted in the SAM format and converted to the BAM output file for analysis 
BWA-MEM is an alignment algorithm that performs mapping of paired-end reads to a reference 
genome (Heng et al. 2013). Tolerance for sequencing errors is 3% error using the BWA-MEM 
algorithm for 200bp. Reads are 151bp long (Heng et al. 2009). The alignment file is outputted in 
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the standard SAM format. The Samtools software package via the Samtools view command line 
was used to extract reads for regions that covered the SMN and outputted in a text file. 
Analysis Programs Developed By Yitao Yan, Hang Li, and Josephine Hoh 
The software was written by computational scientists from Dr. Josephine Hoh’s lab and is still 
currently being revised for improvement. The initial program assesses all of the reads for each 
position and summarizes the sequence with the majority of reads in agreement with each other 
and highlights any mismatches. The output file contains information of the general sequence for 
the gene after consolidating information about all the reads for each position to propose a 
potential single consensus sequence for the sample. The major limitation in this program is that it 
is not sensitive to indels, gaps, and does not take into consideration the quality score of the reads. 
Therefore, the accuracy of the consensus sequence may be reduced.  
The follow up program takes the output from Program 1 and conducts a comparison of the 
sequence file for each sample.  This comparison is conducted between the publicly available 
reference dog sequence (CANFAM3.1) and our sequenced samples. Here, all proposed majority 
sequences for the gene were compared among all samples and to the reference. The summary 
output describes any mismatches in the majority sequence between each sample and to the 
reference sequence.  
Annotation of the Gene 
Annotation for SMN was extracted from NCBI and used for annotating the gene through the 
Integrated Genome Browser software. The annotation is based on the publicly available 
reference genome of the Boxer (CANFAM3.1). This is essentially a “copy and paste” 





DNA Quantification as a Measure for Quality: 
The Nanodrop spectrophotometer is a common lab instrument used to measure the concentration 
of DNA and the A260/280 ratio indicates potential sources of contamination among the samples.  
Among the five dog samples, the mean DNA concentration ranged from 41.2 ng/ul to 50.5 ng/ul. 
The A260/280 ratio is used to determine the presence of protein contamination in the sample. 
Pure DNA samples should have a ratio of 1.8 and a lower value suggests potential contamination 
which may impact downstream application of the DNA for sequencing. Overall, the ratio for all 
of the purified DNA samples ranged between 1.66 to 1.83. Two samples (2d and 6b) suggested 
potential protein contamination and were excluded for WGS sequencing.  
The following measures were obtained via the PicoGreen assay. The range of the concentrations 
for the five samples were between 25.2 ng/ul to 50.7 ng/ul (Table 4). When compared to the 
NanoDrop measurements, the Pico Green reported concentrations at a lower value suggesting 
that the NanoDrop overestimates the actual DNA concentration of the extracted samples. It is 
essential that the quantity and concentration of DNA is sufficient for WGS.  
Data Quality of the Assembly  
The highly conserved SMN gene was used as an example for conducting the comparative 
analysis across dog samples. Read depth was used as a rough measure of the quality for the 
assembly. Using NGS, the whole genome of the dog samples was sequenced with 30X coverage 
and reads of length 151bp. The average read depth across dog SMN for samples 1Y, 2O, and 






Genetic Variation among the three Dog samples in relation to the Reference Gene. 
The SMN region for each of the three samples were extracted and the overall majority 
sequence for the SMN gene was generated. The majority sequence for a position was determined 
by calculating the number of bases for each position. The position with the greatest number of 
consenting reads was the proposed majority sequence for the position. The majority sequence for 
the three samples were compared with the reference SMN sequence.  
Based on the pairwise comparison of the majority sequence between each of the samples 
to the reference SMN sequence, there were no genetic variations identified within the exon 
regions. All of the genetic differences were identified in the intron region. When conducting a 
pairwise comparison of the gene between the three samples and the reference sequence, MW had 
the most genetic differences than 1Y or 2O. This is expected as 1Y and 2O are English Bulldogs 
and is hypothesized to have similar genetic patterns within the gene. MW is a French Mastiff and 
contains the most genetic variation within SMN when compared to the reference which is a 
boxer. The total genetic variation in 1Y, 2O, and MW are 0.12%, 0.10%, and 0.58% 
respectively.  
Comparison of Reference Dog SMN to human SMN1 
Currently we are still developing an algorithm to compare the dog SMN to human SMN1 and 
SMN2. Publicly available programs such as UCSC blat tools were used to conduct the 
comparative analysis between dogs and humans. The reference dog SMN gene was extracted and 
compared to the human SMN1 gene via USCS blat software. SMN1 is located on Chr5: 
70,925,030-70,953,012 (27,983 bp) and the dog SMN is located on Chr2: 54,596,006-54,636,762 
(40,757 bp). The overall genetic similarity between dog SMN and human SMN1 is 89.5%, 
mapping to about 7,413 base pairs in human SMN1. There appears to be conserved regions 
across exons 2 to 7 between human SMN1 and dog SMN. This suggests that these conserved 
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regions may serve an important function in survival among dogs and humans. Among intron 2, 4, 
and 5 in human SMN1 there are conserved sequences between dogs and humans suggesting 
potential regulatory functions within those regions.  
Discussion 
The overarching goal of the project on a large scale is to utilize the dog genome as a 
surrogate to study what is unknown in gene variability in relation to function and diseases in 
understanding human conditions. Dogs were proposed as a candidate primarily because of the 
relatively low variation within breeds but high variation between breeds. The project is 
hypothesis-free, and data are generated in a sequential manner as additional dog samples are 
acquired and added into the growing genome database. In this project, we used a conserved gene 
among dogs, SMN, to understand the genetic variability across dog breeds and to compare with 
human SMN1.  
In our study, we aimed to compare a highly conserved gene across dog breeds to identify 
potential genetic variations that may have biological implications for the progression of SMA. In 
our analysis, we isolated the sequence for the gene across three dogs and compared the sequence 
to the reference dog sequence. We identified a number of SNPs but the differences were located 
in the intron region suggesting that potential difference in the exon regions may exhibit 
deleterious effects in the animal. As additional dog sequences from different breeds are acquired, 
the comparison of SMN will be conducted to better understand the genetic variation of the 
conserved gene. Literature suggests that the clinical progression of hereditary canine spinal 
atrophy is phenotypically similar to human SMA, but the condition is not associated with dog 
SMN (Blazej et al. 1998). Although SMN in dogs may not be associated with HCSMA, the gene 
may play a critical role in survival as it is highly conserved across the three dog samples. 
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The major limitation in the study is that the programs used to generate the majority 
sequence across the gene has flaws. The program does not consider the quality of the reads 
generated by the NGS system. The quality of the sequence is reported as a character that 
corresponds to the level of confidence in calling the sequence for the region. Therefore, the 
major limitation of this analysis is the lack of quality control measures to assess the accuracy or 
precision of the majority sequence that is generated by the program. The reported sequence may 
not be accurate with high certainty. Further research is recommended to develop robust 
algorithms and software programs to process the sequencing data generated by NGS for 
comparative analysis of dog and human genome. Lastly, future approaches in the project will 
include sequencing more dogs across different breeds to build an extensive dog genome 
database. Other potential genes associated with canine and human cancers will be analyzed to 
























































Table 2: NanoDrop measurements of sample genomic DNA: Five 
representative dog samples were extracted and purified. Samples 1Y, 2O, and MW were not 
incorporated in the table. The amount of blood acquired varied and were divided into two or four 
vials depending on the quantity of blood available. The five samples are numbered (1-5) and 
divided into vials labeled (a-d) if applicable. Columns 1 and 2 refers to the ID for each tube. 
Column 3 represents the concentration of DNA measured. Columns 4 and 5 refer to the 260/280 
and 260/230 ratios respectively for each sample tube. Columns 6-9 represent the average DNA 
concentration, standard deviation, minimum concentration, and maximum concentration for each 























Table 3: Qubit Fluorometer Measurements of Sample genomic DNA: The 
DNA concentration of the five representative dog samples were quantified via the Qubit 
Fluorometer. Samples 1Y, 2O, and MW were not incorporated in the table. Columns 1 and 2 
refer to the identification coding for the tube and corresponds to the ID coding used for the 
NanoDrop measurements. Column 3 refers to the reported DNA concentration. Columns 4-5 
refers to the quantity of DNA obtained and the corresponding net DNA concentration yield.  
Sample Code on tube Qubit (ng/ul) Volume (ul) Yield (ng) 
1a+1b Anna-CH-1-DW 30.1 150 4515 
2a+2b Scotia-GL-1-DW 50.7 150 7605 
3a Chevy-GL-CL 25.2 150 3780 
4a RB-DW-110718 45.2 300 13560 






















Table 4: Output for majority consensus sequence for each position 
across the SMN gene for the individual sample. This is a pairwise comparison 
between the sample SMN sequence and the reference dog SMN sequence. Column 1 refers to the 
overall consensus sequence and is determined based on the majority sequence for the position. 
Column 2 refers to the position of the sequence relative to the reference dog sequence. Column 3 
provides the total number of reads identified within each position. Column 4 outputs the different 
base pairs relative to the reference sequence for that position. Column 5 refers to the number of 



















Program 1: Output for Sample 1
• Compares each sample to reference individually, output is text file
Overall consensus sequence Position rel. to Ref # reads Diff BP # Diff BP
***Programs 1 and 2 were developed by Yitao and Josephine***





Table 5: Output of analysis program that compares the overall majority 
sequence for each sample to the reference SMN sequence. Any differences 
in base pairs are denoted by a star. The differences are potential genetic variants or SNPs within 
the SMN gene across the three samples and the dog reference sequence. Column 1 refers to the 
position of the sequence across the SMN gene. Column 2 provides the reference dog sequence for 
the position. Columns 3-5 provides the overall majority sequence for samples 1Y, 2O, and MW 

























• Compares all the samples to each other and to the reference 
sequence, output is text file. 
Position Reference 1Y 2O MW
***Programs 1 and 2 were developed by Yitao and Josephine***
***Heng is currently revising programs 1 and 2 ***
Denotes a difference 






Table 6: Total genetic variation across samples 1Y, 2O, and MW for SMN. 
The overall majority sequence for each sample is compared to the reference SMN. Reference 
SMN is obtained from the publicly available dog genome (CanFam3.1) through the National 

























Table 7: Total genetic variation in SMN across 2,000 bp blocks for 
samples 1Y, 2O, and MW when compared to the reference SMN. The x-
axis refers to the 2,000 base pair block across the SMN gene. The y-axis refers to the total 
number of genetic variation within the 2,000 bp region/ total base pairs in the SMN region. 




Table 8: Total genetic variation across samples 1Y, 2O, and MW for SMN 
when compared with the reference SMN. The x-axis refers to the position across 






Figures 1a-1c: An example of read depth for Samples 1Y, 2O, and MW 
across the dog SMN gene. The x-axis refers to the position within the SMN gene and the 
y-axis refers to the number of reads covering the position. Read depth refers to the number of 
sequenced reads that aligned to the reference sequence for each region. The average read depth 
for sample 1Y was roughly 24-25 reads, for sample 2O was 17-18, and for sample MW was 9-
10. The table below provides details about the total number of reads generated within the SMN 
gene for each sample, the average read depth across the gene, the standard deviation of read 











    Variable |        Obs        Mean    Std. Dev.       Min        Max 
-------------+--------------------------------------------------------- 
       reads |    168,456    24.60          6.76               1         55 
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 Variable |        Obs        Mean    Std. Dev.       Min        Max 
-------------+--------------------------------------------------------- 
















































    Variable |        Obs        Mean    Std. Dev.       Min        Max 
-------------+--------------------------------------------------------- 




Figure 2: The reference dog SMN sequence was compared with the 
human SMN sequence. About 7,413 base pairs aligned with the human SMN sequence on 




























1. A. Ostrander, E., Lindblad-Toh, K., & S. Lander, E. (2004). Sequencing the Genome of 
the Domestic Dog Canis Familiaris. 
2. Deschenes, S. M., Puck, J. M., Dutra, A. S., Somberg, R. L., Felsburg, P. J., & Henthorn, 
P. S. (1994). Comparative mapping of canine and human proximal Xq and genetic 
analysis of canine X-linked severe combined immunodeficiency. Genomics, 23(1), 62-68. 
doi:10.1006/geno.1994.1459 
3. Heather, J. M., & Chain, B. (2016). The sequence of sequencers: The history of 
sequencing DNA. Genomics, 107(1), 1-8. doi:10.1016/j.ygeno.2015.11.003 
4. Institute, N. H. G. R. (2015). Comparative Genomics. Retrieved from 
https://www.genome.gov/11509542/comparative-genomics-fact-sheet/ 
5. Institute, N. H. G. R. (2018). The NHGRI Dog Genome Project. Retrieved from 
https://research.nhgri.nih.gov/dog_genome/ 
6. Kirkness, E. F., Bafna, V., Halpern, A. L., Levy, S., Remington, K., Rusch, D. B., . . . 
Venter, J. C. (2003). The Dog Genome: Survey Sequencing and Comparative Analysis. 
301(5641), 1898-1903. doi:10.1126/science.1086432 %J Science 
7. Li, H. (2013). Aligning sequence reads, clone sequences and assembly contigs with BWA-
MEM (Vol. 1303). 
8. Li, H., & Durbin, R. (2009). Fast and accurate short read alignment with Burrows-
Wheeler transform. Bioinformatics, 25(14), 1754-1760. 
doi:10.1093/bioinformatics/btp324 
9. Liu, L., Li, Y., Li, S., Hu, N., He, Y., Pong, R., . . . Law, M. (2012). Comparison of Next-
Generation Sequencing Systems %J Journal of Biomedicine and Biotechnology. 2012, 
11. doi:10.1155/2012/251364 
10. Mellersh, C., Ostrander, E., Cork, L., & Blazej, R. (1998). Hereditary canine spinal 
muscular atrophy is phenotypically similar but molecularly distinct from human spinal 
muscular atrophy. Journal of Heredity, 89(6), 531-537. doi:10.1093/jhered/89.6.531 %J 
Journal of Heredity 
11. Nizzardo, M., Simone, C., Dametti, S., Salani, S., Ulzi, G., Pagliarani, S., . . . Corti, S. 
(2015). Spinal muscular atrophy phenotype is ameliorated in human motor neurons by 
SMN increase via different novel RNA therapeutic approaches. Sci Rep, 5, 11746. 
doi:10.1038/srep11746 
12. Parker, H. G., Shearin, A. L., & Ostrander, E. A. (2010). Man's best friend becomes 
biology's best in show: genome analyses in the domestic dog. Annu Rev Genet, 44, 309-
336. doi:10.1146/annurev-genet-102808-115200 
13. Shearin, A. L., & Ostrander, E. A. (2010). Leading the way: canine models of genomics 
and disease. Dis Model Mech, 3(1-2), 27-34. doi:10.1242/dmm.004358 
14. van Dijk, E. L., Auger, H., Jaszczyszyn, Y., & Thermes, C. (2014). Ten years of next-
generation sequencing technology. Trends Genet, 30(9), 418-426. 
doi:10.1016/j.tig.2014.07.001 
15. Wurster, C. D., & Ludolph, A. C. (2018). Nusinersen for spinal muscular atrophy. 
Therapeutic advances in neurological disorders, 11, 1756285618754459-
1756285618754459. doi:10.1177/1756285618754459 
 
 
